NZ715562A - Anti-viral compounds - Google Patents
Anti-viral compoundsInfo
- Publication number
- NZ715562A NZ715562A NZ715562A NZ71556211A NZ715562A NZ 715562 A NZ715562 A NZ 715562A NZ 715562 A NZ715562 A NZ 715562A NZ 71556211 A NZ71556211 A NZ 71556211A NZ 715562 A NZ715562 A NZ 715562A
- Authority
- NZ
- New Zealand
- Prior art keywords
- pyrrolidin
- compounds
- benzimidazol
- methyl
- oxobutan
- Prior art date
Links
Landscapes
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Provided are compounds of general formula I, where the variables are as described in the specification. An example of the compounds is methyl { (2S)-1-[(2S)-2-{ 5-[(2R,5R)-5-{ 2-[(2S)-1-{ (2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl} pyrrolidin-2-yl]-1H-benzimidazol-5-yl} -1-(4-phenoxyphenyl)pyrrolidin-2-yl]-1H-benzimidazol-2-yl} pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl} carbamate. The compounds are inhibitors of hepatitis C virus (HCV). Further provided are processes and intermediates for preparing the compounds and pharmaceutical compositions comprising them. A preferred compound is methyl { (2S,3R)-1-[(2S)-2-{ 5-[(2R,5R)-1- { 3,5-difluoro-4-[4-(4-fluorophenyl)piperidin-1-yl]phenyl} -5-(6-fluoro-2-{ (2S)-1-[N-(methoxycarbonyl)-O-methyl-L-threonyl]pyrrolidin-2-yl} -1H-benzimidazol-5-yl)pyrrolidin-2-yl]-6-fluoro-1H-benzimidazol-2-yl} pyrrolidin-1-yl]-3-methoxy-1-oxobutan-2-yl} carbamate.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/903,822 US20110092415A1 (en) | 2009-06-11 | 2010-10-13 | Anti-Viral Compounds |
US12/964,027 US8921514B2 (en) | 2009-06-11 | 2010-12-09 | Anti-viral compounds |
US201161446800P | 2011-02-25 | 2011-02-25 | |
US13/100,827 US8937150B2 (en) | 2009-06-11 | 2011-05-04 | Anti-viral compounds |
NZ62664111 | 2011-10-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ715562A true NZ715562A (en) | 2017-09-29 |
Family
ID=59955228
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ715562A NZ715562A (en) | 2010-10-13 | 2011-10-12 | Anti-viral compounds |
Country Status (1)
Country | Link |
---|---|
NZ (1) | NZ715562A (en) |
-
2011
- 2011-10-12 NZ NZ715562A patent/NZ715562A/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ606645A (en) | Anti-viral compounds | |
NZ710567A (en) | Antiviral compounds | |
NZ600505A (en) | Hepatitis c virus inhibitors | |
PE20160800A1 (en) | METHYL ((1S)-1-(((2S)-2-(5-(4-(2-((2S)-2-((METHOXYCARBONYL)AMINO)-3-METHYLBUTANOYL)-2-PYRROLIDINYL COMBINATION )-1H-IMIDAZOL-5-IL)-4-BIPHENYLYL)-1H-IMIDAZOL-2-IL-1-PYRROLIDINYL)CARBONYL)-2-METHYLPROPYL)CARBAMATE (DACLATASVIR) AND N-(TERT-BUTOXICARBONYL)-3- METHYL-L-VALYL-(4R)-4-((7-CHLORO-4-METHOXY-1-ISOQUINOLINYL)OXYN-((1R,2S)-1-((CYCLOPROPYLSULFONYL)CARBAMOIL)-2-VINYLCYCLOPROPYL) -L-PROLINAMIDE (ASUNAPREVIR). | |
RS54282B1 (en) | Solid compositions | |
DOP2011000298A (en) | METHYL [(2S) -1 - {(2S) -2- [5- (10- {2 - [(2S) -1 - {(2S) -2 - [(METOXICARBONIL) AMINO] -3- METHYLBUTANOYL} PIRROLIDINE -2-YL] -1H-IMIDAZOL-5-YL} -6-PHENYLINDOL [1,2-C] [1,3] BENZOXAZIN-3-YL) -1H-IMIDAZOL-2-YL] PIRROLIDINA-1-YL } -3-METHYL-1-OXOBUTAN-2-YL] CARBAMATE AND USE OF THE SAME TO TREAT HCV INFECTION | |
NZ594981A (en) | Hepatitis c virus inhibitors | |
NZ594068A (en) | Substituted benzimidazole compounds as hepatitis c virus inhibitors | |
AR104566A2 (en) | CRYSTAL FORM OF SALT DICHLORHYDRATE OF ((1S) -1 - (((2S) -2- (5- (4- (2 - ((2S) -1 - ((2S) -2 - ((METOXICARBONIL) AMINO ) -3-METHYLBUTANOIL) -2-PIRROLIDINIL) -1H-IMIDAZOL-5-IL) -4-BIFENILIL) -1H-IMIDAZOL-2-IL) -1-PIRROLIDINIL) CARBONIL) -2-METHYLPROPIL) METHYL CARBAMATE | |
NZ595168A (en) | Hepatitis c virus inhibitors | |
ATE547103T1 (en) | HEPATITIS C VIRUS INHIBITORS | |
NZ600608A (en) | 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors | |
PE20110224A1 (en) | PROCEDURE FOR THE SYNTHESIS OF A PEPTIDOMIMETIC OF Smac INHIBITOR OF IAP, AND INTERMEDIARY COMPOUNDS FOR THE SYNTHESIS OF THE SAME | |
PE20060602A1 (en) | HETEROARYL ACIL PYRROLIDINE DERIVATIVES AS INHIBITORS OF HEPATITIS C VIRUS (HCV) | |
WO2008021927A3 (en) | Hepatitis c virus inhibitors | |
HRP20191939T1 (en) | Methods for treating hepatitis c | |
ATE551337T1 (en) | HEPATITIS C VIRUS INHIBITORS | |
PE20141056A1 (en) | METHODS FOR THE TREATMENT OF HCV | |
WO2008021936A3 (en) | Hepatitis c virus inhibitors | |
MX2010006489A (en) | Crystalline forms of n-(tert-butoxycarbonyl)-3-methyl-l-valyl-(4r )-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-n-((1r,2s)-1-((cyc lopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-l-prolinamide. | |
EA200970805A1 (en) | SERINPROTEAS INHIBITORS FOR THE TREATMENT OF HCV INFECTIONS | |
MX2010006210A (en) | Fluorinated tripeptide hcv serine protease inhibitors. | |
MX2010008109A (en) | Difluorinated tripeptides as hcv serine protease inhibitors. | |
WO2010034105A8 (en) | Hepatitis c inhibitor compounds | |
MX2010008108A (en) | Heteroaryl-containing tripeptide hcv serine protease inhibitors. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 12 OCT 2018 BY SPRUSON + FERGUSON Effective date: 20180131 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 12 OCT 2019 BY THOMSON REUTERS Effective date: 20180917 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 12 OCT 2020 BY THOMSON REUTERS Effective date: 20190917 |
|
LAPS | Patent lapsed |